Molecular Profiling and Real-world Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer.

Overview of attention for article published in Clinical Cancer Research, January 2026

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 70,921 followers.

@VivekSubbiah @OncoAlert https://t.co/uCoRnQ4ZFj

RT @VivekSubbiah: Molecular Profiling and Real-world Outcomes of BRAF V600E–Mutated Papillary Thyroid Cancer | Clinical Cancer Research | A…

Molecular Profiling and Real-world Outcomes of BRAF V600E–Mutated Papillary Thyroid Cancer | Clinical Cancer Research | American Association for Cancer Research https://t.co/nM5ZwUzhAO

The authors compare real-world survival and molecular/transcriptional signatures in patients with BRAF V600E–mutated (BRAF-mut) and BRAF wild-type (WT) papillary thyroid cancers. The former was associated with a proinflammatory TME milieu. @TMWiseDraper …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.